Leflunomide in Combination With Vemurafenib in Patients With V600 Mutant Metastatic Melanoma
Phase of Trial: Phase I/II
Latest Information Update: 07 Apr 2017
At a glance
- Drugs Leflunomide (Primary) ; Vemurafenib (Primary)
- Indications Malignant melanoma
- Focus Adverse reactions; Therapeutic Use
- 04 Apr 2017 Status changed from suspended to discontinued.
- 13 Sep 2016 Planned primary completion date changed from 1 Jul 2015 to 1 Jul 2017.
- 13 Sep 2016 Planned End Date changed from 1 Dec 2015 to 1 Jul 2017.